Skip to main content

Eduardo Vilar Sanchez

NIH Rank #1568
  • Program Leader
  • R01 Holder
  • Translational
  • Top 10% Funded
  • Early Career
  • Diverse Portfolio

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 9809050Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

FY2026 award categories

  • Internal Medicine
  • Genetics

NIH Funding · FY2024

Linked Award Amount
$4.1M
Full award amounts, FY2024
Award Records
7
Records listing this PI
Award-Linked Rank
#1,568
By linked amount among FY2024 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Eduardo Vilar Sanchez. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2024 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2024 award records by amount

NIH award records listing Eduardo Vilar Sanchez as a PI. Multi-PI records show the full award amount for context.

  • 5UG1CA242609-06UG1
    iCAN-PREVENT: MD Anderson International Cancer Prevention Clinical Trial Consortium
    $1.3M
    award amount
  • 5R01CA257375-04R01
    Cancer Immune-Interception for Lynch Syndrome
    $639.4K
    award amount
  • 5R01CA260761-03R01
    Cancer Immune-Interception in a Spontaneous Non-Human Primate Model of Lynch Syndrome
    $606.6K
    award amount
  • 5R01CA257559-02R01
    Immunoepigenetic targeting of MHC regulators in FAP
    $563.3K
    award amount
  • 75N91024D00004-0-759102400002-1N01
    TIME-RESTRICTED FEEDING FOR PANCREATIC CANCER PREVENTION
    $551.7K
    award amount
  • 4P30CA016672-48P30
    Cancer Center Support Grant
    $401.1K
    award amount
  • 75N91024D00004-0-759102400001-1N01
    TO Title: Contract Orientation & Kickoff Meeting for Preclinical Services for PREVENTBase IDIQ Title: PREVENT Cancer Preclinical Drug Development Program: Preclinical Efficacy and Intermediate End
    $3.5K
    award amount

Award organizations

Organizations that administered FY2024 awards listing Eduardo Vilar Sanchez as a PI.

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    UT MD Anderson Cancer Center
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    Entered Top 50% Nationally
    Ranked #1568
  6. 2024
    Entered Top 25% Nationally
    Ranked #1568
  7. 2024
    Entered Top 10% Nationally
    Ranked #1568
  8. 2025
    $5M Cumulative Funding
  9. 2025
    Multi-Institutional Research
    Awards at 2 institutions
  10. 2025
    R01 Grant Holder
  11. 2025
    Program/Center Grant Leader
  12. 2026
    $10M Cumulative Funding